Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Strata Critical Medical, Inc.SRTA · Entity 5512 | Director · Co-CEO and General Counsel | September 24, 2026 | September 25, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Strata Critical Medical, Inc.
Report date September 24, 2026 · Filed September 25, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class A common stock, $0.0001 par value per shareSEC Table I · non-derivative | Direct | 2,153,678 |
Ending reported balance
After 2026-09-24 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2026-09-24 · Grant · Acquired 177,858 · Balance 2,244,475 F1: Represents shares that were acquired upon the certification of the Compensation Committee of the Issuer's Board of Directors of the satisfaction of performance criteria underlying an award of performance-based restricted stock units ("PSUs") granted to the Reporting Person on August 29, 2026 Row 2 · 2026-09-24 · Tax withholding · Disposed 90,797 · Balance 2,153,678 F2: Represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of PSUs |
Filing footnotes · ownership attribution and instrument terms
F1: Represents shares that were acquired upon the certification of the Compensation Committee of the Issuer's Board of Directors of the satisfaction of performance criteria underlying an award of performance-based restricted stock units ("PSUs") granted to the Reporting Person on August 29, 2026
F2: Represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of PSUs
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 03, 2022 Filed Feb 4, 2022 19:29 UTC | Strata Critical Medical, Inc. BLDE · Entity 5512 | Exercise / conversionClass A common stock, par value $0.0001 per share | 5,556 | $0.18 | $1,000.08 |
DisclosureSEC source: 0001779128-22-000009 · wf-form4_164400293123759.xml · nonDerivative · entry 1 Tomkiel Melissa M. · CIK 0001859484 · President and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 424,972 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 11, 2022 Filed Jan 12, 2022 19:08 UTC | Strata Critical Medical, Inc. BLDE · Entity 5512 | Exercise / conversionStock Option (right to buy) · Derivative | 5,555 | $0.18 Strike: $0.18 | $999.90 |
DisclosureSEC source: 0001779128-22-000001 · wf-form4_164201447466955.xml · derivative · entry 2 Tomkiel Melissa M. · CIK 0001859484 · President and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 280,282 Underlying: Class A common stock, par value $0.0001 per share · 5,555 shares Expires 2025-04-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 11, 2022 Filed Jan 12, 2022 19:08 UTC | Strata Critical Medical, Inc. BLDE · Entity 5512 | Exercise / conversionClass A common stock, par value $0.0001 per share | 5,555 | $0.18 | $999.90 |
DisclosureSEC source: 0001779128-22-000001 · wf-form4_164201447466955.xml · nonDerivative · entry 1 Tomkiel Melissa M. · CIK 0001859484 · President and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 419,416 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 16, 2021 Filed Dec 20, 2021 16:37 UTC | Strata Critical Medical, Inc. BLDE · Entity 5512 | GrantClass A common stock, $0.0001 par value per share | 134,364 | $0.00 | $0.00 |
DisclosureSEC source: 0001779128-21-000020 · wf-form4_164001823146494.xml · nonDerivative · entry 1 Tomkiel Melissa M. · CIK 0001859484 · President and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 410,831 F1 · shares: Represents a grant of Restricted Stock Units ("RSUs"), which will be settled in shares of the Issuer's common stock upon vesting. 6.25% (rounded down to the nearest whole number) will vest every three calendar months from January 1,2022 (with the first tranche to vest on April 1, 2022), with any remaining unvested Restricted Stock Units to vest on January 1, 2026, subject to the Reporting Person's continued service to the Issuer. Read SEC document |
| December 14, 2021 Filed Dec 16, 2021 23:25 UTC | Strata Critical Medical, Inc. BLDE · Entity 5512 | Tax withholdingClass A common stock, $0.0001 par value per share | 130,341 | $8.38 | $1,092,257.58 |
DisclosureSEC source: 0001779128-21-000010 · wf-form4_163969712262521.xml · nonDerivative · entry 1 Tomkiel Melissa M. · CIK 0001859484 · President and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 276,467 Read SEC document |
| September 14, 2021 Filed Sep 15, 2021 23:06 UTC | Strata Critical Medical, Inc. BLDE · Entity 5512 | Exercise / conversionStock Option (right to buy) · Derivative | 27,300 | $0.00 Strike: $0.18 | $0.00 |
DisclosureSEC source: 0001062993-21-008657 · form4.xml · derivative · entry 2 Tomkiel Melissa M. · CIK 0001859484 · President & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 285,867 Underlying: Class A common stock, par value $0.0001 per share · 27,300 shares Expires 2025-04-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 14, 2021 Filed Sep 15, 2021 23:06 UTC | Strata Critical Medical, Inc. BLDE · Entity 5512 | Exercise / conversionClass A common stock, $0.0001 par value per share | 27,300 | $0.18 | $4,914.00 |
DisclosureSEC source: 0001062993-21-008657 · form4.xml · nonDerivative · entry 1 Tomkiel Melissa M. · CIK 0001859484 · President & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 406,808 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 13, 2021 Filed Aug 17, 2021 22:05 UTC | Strata Critical Medical, Inc. BLDE · Entity 5512 | GrantClass A common stock, $0.0001 par value per share | 157,583 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-21-007697 · form4.xml · nonDerivative · entry 1 Tomkiel Melissa M. · CIK 0001859484 · President and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 379,508 F1 · shares: Represents a grant of Restricted Stock Units ("RSUs"), which will be settled in shares of the Issuer's common stock upon vesting. 66.67% of the RSUs will vest on July 1, 2023, and the remaining RSUs will vest on July 1, 2024, subject to the Reporting Person's continued service to the Issuer. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.